BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28902529)

  • 1. Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.
    Ekren PK; Ranzani OT; Ceccato A; Li Bassi G; Muñoz Conejero E; Ferrer M; Niederman MS; Torres A
    Am J Respir Crit Care Med; 2018 Mar; 197(6):826-830. PubMed ID: 28902529
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study.
    Kett DH; Cano E; Quartin AA; Mangino JE; Zervos MJ; Peyrani P; Cely CM; Ford KD; Scerpella EG; Ramirez JA;
    Lancet Infect Dis; 2011 Mar; 11(3):181-9. PubMed ID: 21256086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in the design of clinical trials for antibacterial drugs for hospital-acquired pneumonia and ventilator‐associated pneumonia. Proceedings of a workshop co-sponsored by the US Food and Drug Administration, Infectious Diseases Society of America, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine. March 31-April 1 2009.
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-170. PubMed ID: 21058464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V
    Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
    Torres A; Ferrer M; Badia JR
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S48-53. PubMed ID: 20597672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
    Nseir S; Grailles G; Soury-Lavergne A; Minacori F; Alves I; Durocher A
    Clin Microbiol Infect; 2010 Jul; 16(7):902-8. PubMed ID: 19694760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new American Thoracic Society/Infectious Disease Society of North America guidelines for the management of hospital-acquired, ventilator-associated and healthcare-associated pneumonia: a current view and new complementary information.
    Torres A; ;
    Curr Opin Crit Care; 2006 Oct; 12(5):444-5. PubMed ID: 16943723
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy for hospital-acquired pneumonia.
    Liapikou A; Rosales-Mayor E; Torres A
    Expert Opin Pharmacother; 2014 Apr; 15(6):775-86. PubMed ID: 24579912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit.
    Ferrer M; Liapikou A; Valencia M; Esperatti M; Theessen A; Antonio Martinez J; Mensa J; Torres A
    Clin Infect Dis; 2010 Apr; 50(7):945-52. PubMed ID: 20175690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shorter courses of antibiotic treatment for patients with pneumonia.
    Tanday S
    Lancet Respir Med; 2016 Sep; 4(9):691. PubMed ID: 27460162
    [No Abstract]   [Full Text] [Related]  

  • 13. Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bartlett JG; Barie PS; Niederman MS; Wunderink RG
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-3. PubMed ID: 20597654
    [No Abstract]   [Full Text] [Related]  

  • 14. Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
    Kalil AC; Metersky ML; Klompas M; Muscedere J; Sweeney DA; Palmer LB; Napolitano LM; O'Grady NP; Bartlett JG; Carratalà J; El Solh AA; Ewig S; Fey PD; File TM; Restrepo MI; Roberts JA; Waterer GW; Cruse P; Knight SL; Brozek JL
    Clin Infect Dis; 2016 Sep; 63(5):575-82. PubMed ID: 27521441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
    File TM
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
    Martin-Loeches I; Rodriguez AH; Torres A
    Curr Opin Crit Care; 2018 Oct; 24(5):347-352. PubMed ID: 30063491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the clinical pulmonary infection score impact ICU antibiotic days?
    Swoboda SM; Dixon T; Lipsett PA
    Surg Infect (Larchmt); 2006 Aug; 7(4):331-9. PubMed ID: 16978076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    ; ; ; ; Spellberg B; Talbot G
    Clin Infect Dis; 2010 Aug; 51 Suppl 1(Suppl 1):S150-70. PubMed ID: 20597666
    [No Abstract]   [Full Text] [Related]  

  • 19. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective.
    Laessig KA
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.